SS
MCRB icon

Simplicity Solutions’s Seres Therapeutics MCRB Stock Holding History

Simplicity Solutions’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-565
Closed -$26.9K – 1088
2023
Q3 		$26.9K Buy
+565
New +$43.1K ﹤0.01% 975

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplicity Solutions's MCRB Position: Q4 2023 in Review

Simplicity Solutions sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 565 shares — an estimated $26.9K sold.

Simplicity Solutions first reported a position in MCRB in Q3 2023 and held it in 1 quarter. The position peaked at $26.9K in Q3 2023. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Simplicity Solutions reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplicity Solutions sold 565 Seres Therapeutics shares in Q4 2023, an estimated $26.9K.
  • Simplicity Solutions first reported a position in Seres Therapeutics in Q3 2023 and held it in 1 quarter.
  • Simplicity Solutions's Seres Therapeutics position peaked at $26.9K in Q3 2023.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.